Randomized trial measures C-reactive protein to target statin therapy in primary prevention of coronary events, indicating potential benefits.
Statin therapy may be effective in the primary prevention of coronary events among subjects with relatively low lipid levels but with elevated levels of C-reactive protein.
No takes yet. Share an insight, caveat, or question.
Ridker et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: